News

The latest from Velocity Clinical Research

Velocity Investigators Active at the American Diabetes Association (ADA) 83rd Scientific Sessions

June 27, 2023

Julio Rosenstock, MD, and Juan Frias, MD, were featured prominently throughout the American Diabetes Association (ADA) 83rd Scientific Sessions. The prolific researchers also had findings simultaneously published in the New England Journal of Medicine and The Lancet. Dr. Rosenstock is the lead investigator for … Read more

PI Focus: Velocity PI Leads Breakthrough Efforts to Combat Obesity, Diabetes

June 22, 2023

The Velocity Clinical Research team in Los Angeles, CA, is tackling two of the biggest health threats to Americans today: obesity and diabetes. Better still, they’re making tremendous progress against these conditions that exact a terrible toll on quality of life and longevity. Consider … Read more

Velocity PAC Insights: Communicating With Participants, Cutting No-Shows, and Improving Informed Consent

June 16, 2023

Velocity Clinical Research maintains a Participant Advisory Committee (PAC) — a diverse mix of current and past trial participants across the U.S. The PAC’s job? Providing participant input to fine-tune the clinical research process. In this piece, we dig into highlights from PAC’s recent … Read more

PI Focus: Luis De La Cruz, MD on Sleep Apnea

June 12, 2023
Luis De La Cruz, MD

In this ongoing series, Velocity puts the spotlight on innovative Principal Investigators (PIs) whose work is changing the medical landscape at the intersection of research and patient care.  Velocity Team Contributes to Potential Breakthrough Sleep Apnea Treatment Enjoying a good night’s sleep is vitally … Read more

Paul Evans Named a Featured Speaker of the Cornell University Biotech and Pharmaceutical Summit

June 7, 2023

Paul Evans, PhD, President and Chief Executive Officer of Velocity, has been named a featured speaker of the Biotech and Pharmaceutical Management Summit through Cornell University. The summit at Cornell Tech will enable participants to engage with industry leaders and Cornell faculty in small … Read more

Ride4DEI Promotes Stronger Clinical Trial Industry

May 17, 2023
Ride4DEI Promotes Stronger Clinical Trial Industry

CUMBERLAND, MD – It’s been smooth biking so far for the ACRP Ride4DEI team as they wrapped up day three yesterday (May 16) en route from Pittsburgh, PA to Washington, D.C. in an effort to raise money and awareness promoting diversity on all levels … Read more

Velocity Makes Third German Site Acquisition With InterMed

May 4, 2023
Velocity Makes Third German Site Acquisition

Wiesbaden is the second largest city in the Frankfurt Rhine Main region of Germany, with a population of more than 300,000 people. The city is known for its architecture and is one of the oldest spa towns in Europe, with 26 hot springs. It … Read more

Velocity Announces Three C-Suite Hires to Fuel Growth

May 2, 2023

Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical site organization, today announces it has made three C-suite hires, as the company continues to dramatically expand its clinical site and patient organization, bringing research opportunities to more people. Nick Campbell joins as Chief Commercial Officer, … Read more

Four Takeaways From Velocity’s Clinical Trial Participant Advisory Committee

April 19, 2023

To gain deeper insight into the perspectives of clinical trial participants, Velocity has built the Participant Advisory Committee (PAC). The PAC comprises diverse current and past clinical trial participants from across the country. The Velocity PAC convenes regularly to discuss issues and share ideas … Read more

Tyler Adam, MD, Coauthors NEJM Article With Results From Phase 3 Maternal RSV Vaccine Study

April 6, 2023

Tyler Adam, MD, Principal Investigator at Velocity Clinical Research in Hastings, NE, supported the promising MATISSE Phase 3 maternal RSV vaccine study — results of which have been published in the article, “Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants” … Read more

Case Study: Doubling the Average Participation Rate of Diverse Populations in Cognivue’s FOCUS Study

March 22, 2023

Neuroscience company Cognivue enrolled more than double the national average participation rate of diverse populations in its Further the Objective and Clinical Understanding of Cognivue Study (FOCUS) study. Velocity supported the study by enrolling the entirety of the study’s more than 1,500 subjects across … Read more

Velocity is Now a Society for Clinical Research Sites Global Impact Partner

March 16, 2023

Velocity Clinical Research is now a Society for Clinical Research Sites (SCRS) Global Impact Partnership (GIP). Paul Evans, PhD, President and CEO of Velocity, said the company is excited to leverage this partnership to further improve clinical research, both within Velocity and industry-wide. “The … Read more

Learn more about Velocity's capabilities

Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.

Join a remarkable team doing remarkable work

Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.

Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.

Quality. Continuity. Velocity.